Mechanisms of Cell Death Caused by Endoplasmic Reticulum Stress by Huston, Christopher Wilson et al.
Worcester Polytechnic Institute
Digital WPI
Major Qualifying Projects (All Years) Major Qualifying Projects
April 2012
Mechanisms of Cell Death Caused by
Endoplasmic Reticulum Stress
Christopher Wilson Huston
Worcester Polytechnic Institute
Jared Christopher Broberg
Worcester Polytechnic Institute
Kyle Goodsell
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/mqp-all
This Unrestricted is brought to you for free and open access by the Major Qualifying Projects at Digital WPI. It has been accepted for inclusion in
Major Qualifying Projects (All Years) by an authorized administrator of Digital WPI. For more information, please contact digitalwpi@wpi.edu.
Repository Citation
Huston, C. W., Broberg, J. C., & Goodsell, K. (2012). Mechanisms of Cell Death Caused by Endoplasmic Reticulum Stress. Retrieved from
https://digitalcommons.wpi.edu/mqp-all/4166
MQP-BIO-DSA-5292 
MQP-BIO-DSA-5887 
MQP-BIO-DSA-8361 
 
 
 
MECHANISMS OF CELL DEATH CAUSED BY  
ENDOPLASMIC RETICULUM STRESS 
 
 
A Major Qualifying Project Report 
Submitted to the Faculty of the 
WORCESTER POLYTECHNIC INSTITUTE 
in partial fulfillment of the requirements for the 
Degree of Bachelor of Science  
in 
Biology and Biotechnology 
 
By 
 
 
____________________          ____________________          ____________________ 
                Jared Broberg                            Kyle Goodsell                      Christopher Huston 
 
 
April 26, 2012 
 
 
APPROVED: 
 
_________________________   _________________________ 
Fumihiko Urano, MD, PhD    David Adams, PhD 
Program in Molecular Medicine   Biology and Biotechnology 
UMASS Medical Center    WPI Project Advisor 
MAJOR ADVISOR 
 2 
ABSTRACT 
 
 
Wolfram Syndrome is a rare genetic disorder, associated with optic nerve degeneration 
and diabetes mellitus.  Most cases result from mutations in the WFS1 gene encoding wolframin, 
a negative regulator of ATF6α.  Our lab recently showed in pancreatic β-cells that mutated 
wolframin causes hyper activation of ATF6α signaling which increases the protein unfolding 
response, leading to cell death.   In this project, we tested various knockout and wild-type cell 
lines to distinguish which ER pathways are important to stress related apoptosis.  The results 
showed that ATF6α, which has previously been shown to increase ER stress in adult pancreatic 
cells, did not change cell death in embryonic mouse fibroblasts.  However, the PERK and IRE1α 
pathways are important in the cell death of embryonic mouse fibroblasts. 
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BACKGROUND 
 
 
Wolfram Syndrome  
 
Wolfram Syndrome is a rare genetic disorder that can crudely be defined as a 
neurodegenerative form of diabetes mellitus.  It is first diagnosable by the development of 
diabetes mellitus at a young age.  Its prevalence is low with around 1 in 500,000 children 
developing the disease (Barrett and Bundley, 1997).  There is currently no cure.  
 
Original Description 
The disease was first described in four siblings in 1938 by Drs. Don J. Wolfram and HP 
Wagener (Wolfram and Wagener, 1938).  Wolfram and Wagner were studying eight siblings 
between the ages of 3 and 18 years, four of whom had developed diabetes mellitus and optic 
atrophy (Minton et al., 2003).  These two symptoms are the most prevalent in Wolfram’s patients 
and are the first to develop.  The eldest of the four siblings developed diabetes mellitus at age 8 
and optic atrophy at age 11; her brother had symptoms of vision loss at age 6 and developed 
diabetes mellitus at age 10.  The two other siblings developed the same symptoms at similar 
ages, with diabetes mellitus developing at ages 7 and 5, and optic atrophy following a few years 
later (Barrett and Bundley, 1997).  As the children aged the symptoms progressed with two of 
the siblings becoming almost completely blind and developing neurogenic bladders.  Three of 
the four siblings had also lost some sense of hearing (Minton et al., 2003).  
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Additional Cases 
Since the first description of this disease, there have only been around 200 additional 
recorded cases, so the disease is rare.  The additional cases have provided additional symptoms 
including: diabetes insipidus (in which the kidneys cannot conserve water), renal out-flow tract 
abnormalities, and neurological and other endocrine abnormalities. The disease is also referred to 
as DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness).   The 
average onset begins at age 6 with the development of diabetes mellitus.  Next, optic atrophy 
begins at around 11 years old, and vision deteriorates culminating with blindness in most 
patients.  At an average of 14 years, the majority of patients develop diabetes insipidus.  
Deafness begins to present around age 16.  Other neurological and endocrine abnormalities also 
known to develop in patients are cerebral ataxia, peripheral neuropathy, psychiatric illness, 
hypogonadism, and renal tract irregularities.  Ultimately, the disease leads to death around the 
age of 30.  The most common reason for death is from respiratory failure resulting from 
degeneration of the brainstem (Rigoli et al., 2011).  
 
Wolfram Syndrome Genetics 
Wolfram’s has been shown to be passed on through autosomal recessive inheritance 
(Barrett and Bundley, 1997).  It often appears in siblings of the same family, but with no sign of 
the disease in the parents. The Wolfram’s gene was first discovered in 1998 in a collaboration 
between an American/Japanese group (Inoue et al., 1998) and a group led by Dr. Tim Strom 
(Strom et al., 1998).  The first group used positional cloning, and the latter group used a 
candidate gene approach, to identify a gene spanning 33.4 kb on the short arm of chromosome-4 
(Rigoli et al., 2011).  The gene was referred to as WFS1 by the Japanese group, and as wolframin 
 7 
by Tim Strom’s group.  However, to prevent confusion with its protein, in this MQP report we 
will use WFS1 to refer to the gene, and wolframin to refer to the protein. 
A second Wolfram’s gene was identified in patients showing additional symptoms such 
as gastrointestinal bleeding, not seen in the earlier Wolfram’s patients.  After a study of sixteen 
blood related patients from Jordan who had these additional symptoms, scientists determined the 
cases were not linked to the WFS1 gene, but to a different locus on chromosome-4, known as 
WFS2 (Minton et al., 2003). 
Mutations in WFS1 appear to cause the majority of Wolfram’s cases (Rigoli et al., 2011), 
and WFS1 is the better characterized of the two Wolfram’s genes.  Patient screening has revealed 
several types of mutations in WFS1, including nonsense, missense, deletion, insertion, and frame 
shift mutations. The gene itself consists of 8 exons, with most cases showing a mutation in exon 
8, which is significant for disease development.  Translation of WFS1 produces a protein 890 
amino acids long, known as wolframin. The protein is an endoglycosidase H-sensitive membrane 
glycoprotein with 9 transmembrane domains (Takeda et al., 2001).  The protein has been found 
to be mainly localized in the endoplasmic reticulum (ER), especially of heart cells, brain, lungs, 
inner ear, and pancreas.  Among its many functions, the ER is responsible for the folding and 
assembling of newly synthesized proteins.  The role of wolframin in the ER is not yet fully 
understood, but current studies show that wolframin may play a role in the regulation of ER 
stress, and in turn cell survival.  ER stress occurs when the function of the ER is disturbed, 
leading to a buildup of unfolded or misfolded proteins.  Wolframin is believed to negatively 
regulate the protein “activating transcription factor 6α” (ATF6α) which plays a crucial role in the 
unfolded protein response (Rigoli et al., 2011).   
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The Unfolded Protein Response 
Pancreatic β-cell death or dysfunction is one of the biggest contributors to hyperglycemia 
in individuals.  In Wolfram patients, it is believed that ER stress plays a key role in the 
dysfunction and death of β-cells which leads to the hyperglycemia observed in diabetes mellitus 
(Oslowski and Urano, 2010).  When proteins begin to accumulate in the ER, or become 
misfolded, the ER becomes stressed.  ER stress can be caused by hypoxia, oxidative injury, high 
fat diets, protein inclusion bodies, viral infection, or hypoglycemia among others.  As a result of 
ER stress, the cell reacts by undergoing the unfolded protein response (UPR) which is a network 
of signaling pathways (Figure 1).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Diagram of the Unfolded Protein Response (UPR) 
Pathway. The figure depicts the network of signaling pathways involved 
in the UPR.  The three pathways originate with the activation of 
transmembrane proteins IRE1α, PERK, and ATF6α (shown in the upper 
part of the figure) (Kim et al., 2008).  
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The excess proteins present during stress bind to chaperone proteins present in the ER 
which begin folding the proteins.  This results in the release of specific transmembrane proteins 
into the ER lumen, which starts the UPR.  The transmembrane proteins crucial for the initiation 
of the UPR are PRKR-like ER kinase (PERK), inositol-requiring kinase 1 (IRE1), and activating 
transcription factor 6 (ATF6α) (shown top left to right in the figure).  Together these three 
transmembrane proteins increase the expression of ER chaperones, which can then try to 
ameliorate the accumulation of the misfolded proteins (Kim et al., 2008).  Once the UPR is 
triggered, the pathway begins to undergo three effector functions: adaptation, alarm, and 
apoptosis.  The initial response is to upregulate the expression of chaperones to aid in folding the 
accumulated proteins.  If the cell has reached homeostasis after the upregulation of the 
chaperones, the UPR has a built in feedback response that will shut off the pathway (diagram 
center).  If the accumulation continues and the stress is deemed unsolvable by the cell, it will 
enter apoptosis (Kim et al., 2008).   
 
IRE1 
 
IRE1 is a type I transmembrane protein receptor that consists of an ER lumen domain, a 
transmembrane region, and a cytoplasmic domain, and is one of the key proteins in the activation 
of the unfolded protein response (UPR) (Lee et al., 2008).  The different signal pathways that 
IRE1 activates are shown in Figure 1.  IRE1 is required for the cleavage and post-transcriptional 
degradation of several different mRNAs that encode secreted proteins, for example insulin in β-
cells.  This mRNA cleavage and degradation reduces the load on the ER and thereby reduces 
some of the stress.  
 Another pathway that IRE1 is responsible for, which aids in the adaptation reaction of 
the UPR, involves its endoribonuclease domain.  This domain processes an intron from the x-
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box-binding protein 1 (XBP1) mRNA, allowing it to be translated to protein XBP1 (yellow in the 
figure), which forms a heterodimer with another protein called NF-Y.  Together this new 
heterodimer complex is capable of promoting several different genes involved in the UPR (Kim 
et al., 2008).  
 If the ER stress conditions are unsolvable by other means, IRE1 is also able to activate 
apoptotic pathways.  Under these conditions, IRE1 is able to work together with TNF receptor-
associated-factor 2 (TRAF2) (diagram upper center) to activate protein kinases thought to aid in 
immunity, inflammation, and apoptosis (Kim et al., 2008).  The most notable of these protein 
kinases is MAP3K5 (shown as MKK6/7 in the figure) which causes the activation of JNK 
(diagram center right).  JNK (Jun N-terminal kinase) is an enzyme that when activated is able to 
aid in transcription, cell growth, oncogenic transformation, cell differentiation, and cell death 
(Weitzman, 2000). 
 
PERK 
 PERK is another one of the transmembrane proteins responsible for initiating the UPR 
pathways.  Typically IRE1 is seen as the primary regulator of the pathway, and PERK is seen as 
the second in command.  PERK is found abundantly in pancreatic β-cells and has been shown to 
have an effect on β-cell growth and proliferation (Oslowski and Urano, 2010).  During the 
adaptation (effector) pathway of the UPR, PERK phosphorylates and inactivates eukaryotic 
translation initiation factor 2α (EIF2α) (diagram upper left).  The phosphorylation of EIF2α 
results in the repression of protein translation.  By limiting the translation of protein, PERK is 
able to slow the influx of new protein into the ER, which eases the burden (Hamanaka et al., 
2005).   
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 The phosphorylation of EIF2α also stimulates the translation of several mRNAs that 
encode for short upstream open reading frames.  Of these mRNAs is one encoding ATF4, a bZIP 
transcription factor (purple, diagram lower left).  ATF4 is then either able to bind as a 
heterodimer with NRF2 to produce an antioxidant response, or to form a heterodimer with 
C/EBP to induce the transcription factor CHOP (yellow, diagram center).  CHOP is then able to 
promote apoptosis of the cell by inhibiting a gene that encodes for an anti-apoptotic protein 
known as Bcl-2 (Schroder, 2006). 
 
ATF6α 
 ATF6α is the third transmembrane protein responsible for initiating UPR pathway.  Of 
the three transmembrane proteins, ATF6α has been found to be the most associated with 
Wolfram Syndrome.  ATF6α protein is activated in a different way than either of the other two 
pathways.  During ER stress, instead of activating other proteins through phosphorylation, the 
cytosol domain of ATF6α, comprised of around 400 amino acids, is released and travels to the 
Golgi (Thuerauf et al., 2004). Once in the Golgi, ATF6α is cleaved, forming active transcription 
factor proteins that are transported to the nucleus where they upregulate the expression of genes 
responsible for protein folding, processing, and degradation.   If ATF6α becomes hyperactive 
due to an unsolvable accumulation of protein, it results in dysfunction and cell death.   The 
specific effectors for this cell death pathway are currently not fully understood (Oslowski and 
Urano, 2010).   
 Recently, scientists at the University of Massachusetts Medical School have discovered 
that the WFS1 gene is a key negative regulator of the UPR (Oslowski and Urano, 2010).  The 
group found that the wolframin protein encoded by WFS1 is integral in the regulation of ATF6α.  
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Wolframin functions as a negative inhibitor in healthy cells by preventing the activation of 
ATF6α signaling.  During ER stress conditions, normal wild-type wolframin releases ATF6α 
which allows it to go free and act as a transcription factor, as it normally would during ER stress.  
After the ER stress is mediated wolframin degrades the active ATF6α.  However, if the 
conformation of wolframin is changed due to a mutation, such as with Wolfram Syndrome 
patients, then ATF6α escapes from wolframin degradation, and AFT6α is always in a state of 
hyperactivation, which leads to death of the pancreatic β-cell (Oslowski and Urano, 2010). 
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PROJECT PURPOSE 
 
 
 The purpose of this project is to help identify which ER pathways are important in stress-
related apoptosis.  ER stress will be induced in embryonic mouse fibroblast cell lines using 
various toxins such as Tg and Tm, and the responses to the toxins will be measured by 
immunoblots for proteins related to apoptosis (such as caspase-2, caspase-3, caspase-9, and 
housekeeper GAPDH).  The responses will be measured in knockout and WT cell lines for 
PERK, IRE1α, ATF6α transcription factor markers for key stress pathways. 
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MATERIALS & METHODS 
 
Embryonic Mouse Fibroblast Cell Lines 
Four different mouse embryonic fibroblast cell lines were used in this project:  WT, 
ATF6α KO, IRE1α KO, and PERK KO.  These cell lines were obtained from two different 
sources. The IRE1α KO and PERK KO cell lines were acquired from David Ron at the 
University of Cambridge, and the ATF6α KO cell line was acquired from Randal J. Kaufman at 
the Sanford-Burnham Medical Research Institute.  
 
Embryonic Mouse Fibroblast Cell Line Growth 
All embryonic mouse fibroblasts were grown in DMEM 1X EAGLE’s medium 
(Mediatech Inc.) supplemented with 10% FBS and 1% Penn-Strep.  Cells were grown at 37°C in 
5% CO2 to confluency, then split.  Trypsin-EDTA was used to remove the attached cells from 
the plate.  The spent medium was aspirated, and the cells were rinsed with 10 mL of 1X PBS.  
The wash was aspirated, then 1.0 mL of Trypsin-EDTA was added.  The flask was incubated at 
room temperature until the cells loosened from the bottom of the plate. Then, 10 mL of pre-
warmed medium was added, and the cell suspension was centrifuged for 5 minutes at 1000 rpm.  
The supernatant was aspirated, and the cell pellet was re-suspended in 3 mL of pre-warmed 
medium. 1.0 mL of cell suspension was added to each of the three cell culture plates containing 9 
ml of medium.  
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Cell Plating into 12-Well Plates 
The medium was aspirated from a confluent flask, and the flask rinsed with 10 ml of 1X 
PBS.  The wash was aspirated, then 1 mL of Trypsin-EDTA was added to the attached cells.  
The flasks were left at room temperature for 1-2 minutes until the cells unattached.  10 mL of 
pre-warmed medium was added to the cell suspension, and the suspension was transferred to a 
15mL conical tube and centrifuged for 5 minutes at 1000 rpm.  The medium was aspirated, then 
the cell pellet was re-suspended in 10 mL of pre-warmed medium.  100 µL of the cell suspension 
was mixed with an equal volume (100 µL) of Trypan Blue Dye to make a dilution factor of 2.  
The mixture was pipetted up-and-down to mix, then 1 µL of the solution was added onto a cell 
counting slide.  The number of cells was counted in one of the grids, and the following equations 
were used to calculate the number of cells per mL, and to determine the volume containing 3 x 
10
5
 cells per well: 
Eq. 1: (# of cells in one grid) * (10^4) * (dilution factor) = cells per mL in sample.  
For example, (45) * (10^4) * (2) = 9.0 x 10
6
 cells/mL 
 
Eq. 2: (Target # of cells) / (cells per mL in sample) = mL of cell solution to add 
per well.  For example, (3*10^5) / (9,000,000) = 0.333 mL of cell solution to 
add per well. 
 
The volume corresponding to 3 x 10
5
 cells was added to each well of a 12-well microtiter 
plate, then pre-warmed medium was added to make a total volume of 1 mL.  The plate was 
incubated 2 nights at 37°C in 5% CO2. 
 
Induction of ER Stress and Cell Harvesting 
Two days after plating, the medium was aspirated from each well of the 12-well plate, 
and the cells were rinsed with 1 mL of 1XPBS.  The wash was aspirated, and 1 mL of pre-
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warmed medium was added to each well. A 1 mM stock solution of Thapsigargin (Tg) was 
diluted 1:100 (to make 10 µM) by adding 1 µL to 100 µL of medium, and the solution was 
vortexed to mix. 10 µL of the 10 µM dilution was added to an appropriate well to make a final 
concentration of 0.1 µM.  Next, the 5 mg/mL Tunicamycin (Tm) stock solution was diluted 
1:5000 (to make a 1 µM dilution) by adding 1 µL of the 5 mg/mL main stock solution to 50 µL 
of medium.  The mixture was vortexed to mix, then 10 µL of the dilution was added to an 
appropriate well (to make a final concentration of 0.01 µM).  The microtiter dishes were 
incubated at 37°C for another 24 hours. 
Following the 24 hr incubation, the spent medium was collected in a conical tube and the 
wells were washed with 1 mL of 1X PBS.  The wash was also collected in the conical tube, then 
0.2 mL of Trypsin-EDTA was added to each well to loosen the cells from the bottom of the 
wells. Once the cells loosened, 1 mL of pre-warmed medium was added to each well, and the 
cell suspension was transferred to the same conical tube as the old medium and the PBS wash.  
The tubes were centrifuged at 1000 rpm for 5 minutes, and the supernatant was aspirated, 
making sure to not aspirate the cell pellet at the bottom of the tube.  1 mL of 1X PBS was added 
to the cell pellet, and the tube was centrifuged again for 5 minutes at 1000 rpm. The wash was 
aspirated, and the cell pellet was re-suspended in 50 µL of M-PER solution. The samples were 
frozen at -20°C for later use, or the protein concentration was determined (below). 
 
Protein Concentration of Lysate Samples 
A 50 µL cell lysate samples was defrosted, and the sample was transferred to a 1.5mL 
Eppendorf tube.  The tube was centrifuged for 5 minutes at 1000 rpm to remove cell debris, and 
the supernatant was transferred to a new 1.5mL Eppendorf tube, making sure to leave the solid in 
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the old tube. The protein concentration was determined by comparison of an aliquot of the 
sample’s absorbance at 280 nm compared to a sample of distilled water, which acted as the 
baseline with no protein present.  The dilution required to produce a final protein concentration 
of 20 µg/µL was calculated by using the Equation below: 
 
Eq. 3: 20 µg / (protein concentration in µg/µL) = target amount of lysate in µL 
For example: (20 µg) / (6.18 µg/µL) = 3.2 µL of sample needed. 
 
Once the appropriate concentrations and volumes were calculated, the amount of 4X Sample 
Buffer and distilled water needed to bring the sample to a total volume up to 25 µL were 
determined.  Mixed samples were either frozen for later use, or were immediately used for a 
Western Blot. 
 
Western Blots 
Samples prepared as described above containing 20 µg of protein in 25 µL were placed 
on a 95°C heating block for 5 minutes to denature the protein. Tubes were briefly centrifuged to 
remove the condensation from the lid.  A 5%-15% polyacrylamide gel (Biorad) was retrieved 
from 4°C storage, and the strip was removed from the bottom of the gel. The gel was placed into 
the electrophoresis unit with the smaller side of the glass facing the inside of the unit so the well 
labels can be read from outside. The comb was gently removed, making sure not to disrupt the 
wells.  1X Running Buffer was poured into the middle of the gel unit and on both sides so that 
the level was above the wells, making sure not to get the electrodes on top wet. 10 µL of the 
Biorad Precision Protein Dual Color Standard marker was loaded into Lane 1 using a gel loading 
tip, making sure to record which lane the marker was placed in. The other wells were loaded 
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with the 25 µL of the samples, making sure to label which sample was placed in each lane. The 
electrodes were connected to the apparatus, making sure to match up the colors. The gel was run 
at 30 amps (for one gel) or 60 amps (for 2 gels) for 30-60 min, or until the bromphenol blue dye 
reached the bottom of the gel. 
While the gel was running, an ice pack was filled ice and water, and stored at -80°C. Two 
fiber pads, 2 pieces of pre-cut filter paper, and a single PVDF membrane were obtained.  The 
former two were soaked in 1X Transfer Buffer, while the PVDF membrane was soaked in 
methanol.  Once the gel was done running, the gel was removed from the plate by using a special 
tool that came with the gel package. The wells were removed using a spatula, taking care not to 
rip the gel. The gel was placed in 1X Transfer Buffer.  The immunoblot transfer apparatus was 
obtained and the gel sandwich was assembled on the black side of the cassette in the following 
order: First was placed a fiber pad, then a piece of filter paper, then the gel was carefully placed 
on top of the sandwich, again taking care not to rip the gel. Next, the the membrane was 
carefully placed onto the gel, taking care to have all of the samples on the gel covered by the 
membrane. The bubbles were cleared from the membrane, using the spatula to smooth the 
membrane. Next, a piece of filter paper was added, then finally the last fiber pad was added. The 
sandwich was clamped together, and the cassette inserted into the electrode module, making sure 
the black side is next to the black side of the electrode module. The icepack was retrieved, and 
placed on the open side of the apparatus. The tank was filled with 1X Transfer Buffer, and the 
electrodes were attached to the appropriate leads.  The electroblot was run at 100 V for 60 
minutes. 
While the transfer was in progress, the blocking buffer was prepared by mixing 5 g of 
BSA or non-fat milk with 100 mL of TBST to make a 5% solution. Once the transfer was 
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complete, the sandwich was disassembled, and the membrane was placed in an immunoblot box 
with 10-20 mL of blocking solution. The box was rocked for 1 hour at room temperature, making 
sure the membrane could move back and forth in the box. 
Once the blocking hour was completed, the blocking solution was dumped, and the 
membrane was washed 3 times using TBST, rocking for 5 minutes each time at room 
temperature.  Enough TBST was used to completely cover the membrane and allow it to move. 
Once the washes were finished, they were discarded, and 10 mL of fresh blocking solution was 
added into the container, along with 10 µL of primary antibody.  The primary antibodies used 
were used were: GAPDH (CellSignaling 14C10, rabbit), Cleaved Caspase-3 (CellSignaling 
D175, 5A1E, rabbit), Caspase-2 (Millipore, rat), or Caspase-9 (CellSignaling, C9, mouse).  
Incubations with the primary antibodies were for overnight in the cold room.  
The next day, the primary antibody solution was discarded, and the membrane was 
washed 3X with TBST as described above for 5 minutes each, then the membrane was placed in 
10 mL of fresh blocking solution and 3 µL of the appropriate secondary antibody was added to 
the solution, depending on which primary antibody was used.  Secondary antibodies used were: 
HRP-conjugated anti-mouse IgG (CellSignaling), HRP-conjugated anti-rat IgG (CellSignaling), 
or HRP-conjugated anti-rabbit IgG (EBioScience).  Incubations with secondary antibodies were 
at room temperature for 30 minutes on the rocker. 
After the secondary antibody incubation, the membrane was washed 3X with TBST as 
described before, for 5 minutes each. Then 1 mL of fresh ECL Western Blotting Substrate 
(Pierce) was prepared for each membrane being visualized. The membranes were placed on a 
piece of plastic, and 1 mL of the solution was added and spread over each membrane. The 
membranes were incubated for 1 minute, then the membrane was lifted using tweezers and 
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placed between two plastic layers inside an Immunoblot Cassette, making sure to wipe away any 
excess drops of liquid.  In the darkroom, one piece of x-ray film was placed into the cassette, and 
the film was exposed for 5 minutes.  Sometimes the film was exposed longer if needed.  The 
exposed film was placed inside the automatic film developer, and the button was pushed to feed 
the film into the machine. 
 
 
Figure-2: Flow Chart of the Procedures Done for this Project. This 
flow chart shows the general experimentation methods followed in this 
project. This approach was performed several times to attain multiple 
trials for each antibody. The antibodies used were for GAPDH (control), 
Caspase-3, Caspase-2 and Caspase-9. 
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RESULTS 
 
 
 
 In this project, endoplasmic reticulum (ER) unfolded protein response (UPR) pathways 
resulting from ER stress were analyzed for their importance in embryonic fibroblast cells.  Four 
different cell lines, three with different UPR pathways knocked out and a wild type control, were 
each treated with two different toxins (Tm or Tg) to induce ER stress.  Once ER stress was 
induced, the cells were lysed and the levels of cleaved caspase-3 (a marker for apoptosis) were 
determined by immunoblots.  GAPDH was used as a load marker.  Caspase-3 was assayed 
because it is critical for apoptosis, and its cleavage is indicative of cell death.  Figures 3-7 below 
show the western blots for four separate trials.  The four trials were performed to ensure the 
reproducibility of the results.  In order to fit all of the samples into four gels an unusual ordering 
was used.  The contents of each lane are explained in detail in each figure legend. 
 
 
 
 
 
 
Figure-3: First Half of Trial-1 for All Cell Lines.  Caspase-3 cleavage 
was observed in PERK-KO and IRE1α-KO Tg treated cells.  (1) Trial 1 
WT untreated, (2) Trial 1 ATF6-KO untreated, (3) Trial 1 IRE1α-KO 
untreated, (4) Trial 1 PERK-KO untreated, (5) Trial 1 WT Tg treated, (6) 
Trial 1 ATF6α-KO Tg treated, (7) Trial 1 IRE1α-KO Tg treated, (8) Trial 
1 PERK-KO Tg treated, (9) Trial 3 WT untreated. 
 
 
The first trial (Figure-3) showed capsase-3 cleavage in IRE1α-KO (lane-7) and PERK-
KO (lane-8) cell lines treated with Tg.  The amount of capase-3 cleavage is small compared to 
the amounts of un-cleaved caspase-3.  However, the presence of the cleaved caspase-3 shows 
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that cell death is occurring in these cells.  Figure-4 shows the second part of trial-1 (Tm samples 
only) and the first part of trial-2.  Once again, the lanes loaded with trial-1 TM-treated IRE1α-
KO (lane-3) and PERK-KO (lane-4) showed faint evidence of cleavage of caspase-3, however 
the equivalent samples for trial-2 (lanes-7 and 8) showed no cleaved caspase-3.  
 
 
 
 
 
Figure 4: Second Half of Trial-1 and First Half of Trial-2 for All Cell 
Lines.  Slight caspase-3 cleavage was observed in PERK-KO and 
IRE1α-KO Tm treated cells.  (1) Trial 1 WT Tm treated, (2) Trial 1 
ATF6-KO Tm treated, (3) Trial 1 IRE1α-KO Tm treated, (4) Trial 1 
PERK-KO Tm treated, (5) Trial 2 WT untreated, (6) Trial 2 ATF6α-KO 
untreated, (7) Trial 2 IRE1α-KO untreated, (8) Trial 2 PERK-KO 
untreated, (9) Trial 3 ATF6α-KO untreated. 
 
 
The second half of trial-2 is shown in Figure-5.  A slight caspase-3 cleavage was still 
observed in Tm-treated PERK-KO cells (lane-8) and Tg-treated IRE1α-KO (lane-3), but no 
observable cleavage for Tm-IRE1α-KO or Tg-PERK-KO as was seen in trial 1. 
 
 
 
 
Figure-5: Second Half of Trial-2 Results.  Very slight caspase-3 
cleavage was observed in PERK-KO cells treated with Tm and IRE1α-
KO cells treated with Tg. (1) Trial 2 WT Tg treated, (2) Trial 2 ATF6-
KO Tg treated, (3) Trial 2 IRE1α-KO Tg treated, (4) Trial 2 PERK-KO 
Tg treated, (5) Trial 2 WT Tm treated, (6) Trial 2 ATF6α-KO Tm 
treated, (7) Trial 2 IRE1α-KO Tm treated, (8) Trial 2 PERK-KO Tm 
treated, (9) Trial 3 IRE1α-KO untreated. 
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Figure-6 shows the results for trial-3, which showed strong cleavage for Tm-IRE1α-KO 
(lane-7) and Tm-PERK-KO (lane-8), but only slight or no cleavage for the equivalent Tg-treated 
samples.   
 
 
 
 
Figure-6: Trial-3 Results.  Caspase-3 cleavage was observed in PERK-
KO and IRE1α-KO cells treated with Tm.  (1) Trial 3 WT Tg treated, (2) 
Trial 3 ATF6-KO Tg treated, (3) Trial 3 IRE1α-KO Tg treated, (4) Trial 
3 PERK-KO Tg treated, (5) Trial 3 WT Tm treated, (6) Trial 3 ATF6α-
KO Tm treated, (7) Trial 3 IRE1α-KO Tm treated, (8) Trial 3 PERK-KO 
Tm treated, (9) Trial 3 PERK-KO untreated. 
 
   
 After obtaining these results, a fourth trial was performed for just the PERK and IRE1α 
samples (Figure-7).  In this trial, a very significant amount of cleaved caspase-3 was observed 
for the Tm-PERK-KO and Tm-IRE1α-KO cells, which backs up the data obtained in the 
previous three trials.  In this case, the PERK-KO and IRE1α -KO cell lines showed caspase-3 
cleavage when treated with either toxin (Tg or Tm).   
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Figure-7: Trial-4 Results for IRE1α-KO and PERK-KO Samples. 
Significant caspase-3 cleavage was observed in PERK-KO and IRE1α-
KO cells treated with Tm.  (1) WT untreated, (2) IRE1α-KO untreated, 
(3) PERK-KO untreated, (4) WT Tg treated, (5) IRE1α-KO Tg treated, 
(6) PERK-KO Tg treated, (7) WT Tm treated, (8) IRE1α-KO Tm treated, 
(9) PERK-KO Tm treated. 
 
For all four trials, no cleavage of caspase-3 was observed for any of the ATF6α-KO cells.  
This is a significant finding as it shows that the ATF6α pathway is not as critical in murine 
fibroblast cells as the other pathways.  In all cases, the ATF6α-KO cells produced the same 
results as the wild type cells, showing that the ATF6α pathway provides little help in relieving 
ER stress in the fibroblasts, so it is mostly the PERK and IRE1α pathways.  The PERK and 
IRE1α pathways are concluded to be more important because when they are knocked out, cell 
death increases, so the cells were unable to relieve the stress in the absence of those two 
pathways.  Although these two pathways appear to be important for the ER stress response in 
mouse embryonic fibroblasts, the results did not provide any conclusive evidence showing which 
of these two pathways are the more important of the two.  
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DISCUSSION 
 
The purpose of this project was to help identify which endoplasmic reticulum (ER) 
pathways are important in stress-related apoptosis.  The hypothesis formed by the lab is that the 
ATF6α pathway is not as important in embryonic mouse fibroblasts as it is in adult pancreatic β-
cells.  ER stress was induced in various KO embryonic fibroblast cell lines using toxins Tg and 
Tm, and the responses to the toxins were measured by immunoblots for caspase-2 (data not 
shown), caspase-3, and caspase-9 (data not shown), which are proteins related to apoptosis.  The 
responses were measured in knockout and WT cell lines for PERK, IRE1α, and ATF6α 
transcription factor markers for key stress reduction pathways. 
The main conclusion is that the ATF6α pathway is not important for alleviating ER stress 
in mouse embryonic fibroblast cells, while IRE1α and PERK pathways are.  The results provide 
the first information on these pathways in embryonic fibroblasts.  IRE1α and PERK knockout 
cells showed cleaved Caspase-3, whereas the ATF6α was no different than the Wild Type.  
Figure-8 below summarizes the findings, showing which pathways are important in regulating 
ER stress in embryonic mouse fibroblasts (highlighted in green), and which pathway appears to 
not be involved (crossed out in red). 
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Figure-8: Diagram of the Important UPR Pathways in Mouse 
Embryonic Fibroblast Cells. This figure highlights the pathways that  
have been shown to be of more importance in regulating ER stress in 
embryonic mouse fibroblasts (highlighted in green) as well as indicating 
which pathway plays a lesser role in the regulation of ER stress (crossed 
off in red). 
 
 
This data shows importantly that the ER stress reduction pathways change from early in 
life (embryonic fibroblasts) to later in life (adult pancreatic β-cells).  The data also shows that 
embryonic mouse fibroblasts are more susceptible to stress caused by cell cycle arrest in the G1 
phase, which is how the tunicamycin (Tg) induced stress in the cells. 
Some of the problems that arose during the project were outdated protocols for pancreatic 
cells when embryonic cell protocols should have been used.  Also, some of the Western blots did 
not show the proper bands or any bands at all, leading us to believe that there may have been 
something wrong with the specific antibodies used.  Due to this we were unable to gather any 
conclusive data for the Caspase-2 and Caspase-9 antibodies. 
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There were several things that could have been done to increase the efficiency of the 
assays that we performed. The first was to decrease the dilutions for the antibodies being used, 
both primary and secondary. This would have allowed them to bind to the membrane better and 
would have fluoresced better once the membrane was visualized. We could also have tried 
loading more protein per lane for the gels.  It is also possible that the antibodies that we used for 
Caspase-2, Caspase-9 or one of the secondary antibodies did not work as effectively as believed. 
Numerous Western Blots were performed, but the only data that was obtained for both Caspase-2 
and Caspase-9 probes was inconclusive. 
 
Perspectives 
This project extended the work of several of the papers cited in the Background section.  
Kim et al. (2008) provides a link between β-cell cell death and ER stress in the UPR, and 
specifically the function for each of the pathways that were also investigated in this project. 
Oslowski and Urano (2010) provide the link between ER stress and the death of β-cells in 
relation to Wolfram patients. Rigoli et al. (2011) links the WFS1 mutations to effects on 
ATF6α which plays a crucial role in the UPR for pancreatic β-cells. These three papers played a 
key role in setting the stage for this project. 
 
Future Experiments 
Of the three pathways thought to be involved in the ER Unfolded Protein Response, 
ATF6α has been shown to be the most important of the three pathways in pancreatic β-cells 
found later in life. However, our results have shown that the ATF6α pathway is less important in 
embryonic mouse fibroblasts. This difference logically leads to the question of what is the timing 
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of this change in importance, as well as what causes this shift in significance. This alteration 
from fibroblasts to pancreatic β-cell might hold a clue that will aid in the resolution of the 
question of what is the mechanism of WFS1 when it is mutated and leads to ER stress, which in 
turn takes a part in Wolfram’s syndrome. 
 An additional question to be resolved is if the pathways that regulate ER stress become 
defective, could they be stimulated so that they become effective again. Another possibility 
instead of stimulating the defective pathway could be to imitate the mechanism for the defective 
pathway, which would compensate for that pathway being defective. If the mechanisms for those 
pathways and their relationship to the mutation in WFS1 could be identified, it might be possible 
to provide a way to alleviate the ER stress caused by the disease and discover a way to help 
alleviate the symptoms of Wolfram’s syndrome. 
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